| Literature DB >> 22960635 |
James G Jackson1, Guillermina Lozano.
Abstract
The tumour suppressor p53 directs cells towards different fates depending on the cell type and the stimulus. The decision to direct a cell towards apoptosis rather than cell-cycle arrest or senescence has important implications for tumour suppression in normal cells and drug response in tumour cells. Cells that undergo senescence and growth arrest can persist and contribute to organismal ageing (Campisi, 2005), or they can contribute to tumour relapse (Jackson et al, 2012). In this issue of The EMBO Journal, Höpker et al (2012) show in a comprehensive study that the RNA PolII binding protein CHE1/AATF is a factor that determines the fate of cells that have activated the p53 pathway.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22960635 PMCID: PMC3474930 DOI: 10.1038/emboj.2012.258
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598